Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide. 1996

V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
Rheumatology Division, Hospital Universitario M. Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

Severe mononeuritis multiplex in systemic lupus erythematosus (SLE) is quite rare and almost always accompanied by evidence of active disease in other organs, although occasionally it may be the presenting feature of the disease. We describe here two patients with SLE who presented a severe mononeuritis multiplex secondary to a necrotizing vasculitis which respond successfully to therapy with intravenous cyclophosphamide, and review the literature of similar cases.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009443 Neuritis A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA. Polyneuritis,Neuritis, Motor,Neuritis, Peripheral,Neuritis, Sensory,Motor Neuritides,Motor Neuritis,Neuritides,Neuritides, Motor,Neuritides, Peripheral,Neuritides, Sensory,Peripheral Neuritides,Peripheral Neuritis,Polyneuritides,Sensory Neuritides,Sensory Neuritis
D010488 Polyarteritis Nodosa A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME. Essential Polyarteritis,Necrotizing Arteritis,Periarteritis Nodosa,Arteritides, Necrotizing,Arteritis, Necrotizing,Essential Polyarteritides,Necrotizing Arteritides,Polyarteritides, Essential,Polyarteritis, Essential
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
July 2012, Indian pediatrics,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
April 1992, The Indian journal of medical research,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
January 2013, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
June 1994, Ryumachi. [Rheumatism],
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
January 1988, Annals of internal medicine,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
January 2005, Indian journal of dermatology, venereology and leprology,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
July 2004, Pediatric nephrology (Berlin, Germany),
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
August 1998, Ryumachi. [Rheumatism],
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
January 1992, Contributions to nephrology,
V M Martinez-Taboada, and R B Alonso, and J Armona, and J L Fernandez-Sueiro, and C Gonzalez Vela, and V Rodriguez-Valverde
June 2020, International journal of rheumatic diseases,
Copied contents to your clipboard!